rs148677577
Variant names:
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_006267.5(RANBP2):c.4760G>T(p.Gly1587Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0015 in 1,614,060 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0019 ( 1 hom., cov: 31)
Exomes 𝑓: 0.0014 ( 6 hom. )
Consequence
RANBP2
NM_006267.5 missense
NM_006267.5 missense
Scores
9
9
Clinical Significance
Conservation
PhyloP100: 1.36
Publications
6 publications found
Genes affected
RANBP2 (HGNC:9848): (RAN binding protein 2) RAN is a small GTP-binding protein of the RAS superfamily that is associated with the nuclear membrane and is thought to control a variety of cellular functions through its interactions with other proteins. This gene encodes a very large RAN-binding protein that immunolocalizes to the nuclear pore complex. The protein is a giant scaffold and mosaic cyclophilin-related nucleoporin implicated in the Ran-GTPase cycle. The encoded protein directly interacts with the E2 enzyme UBC9 and strongly enhances SUMO1 transfer from UBC9 to the SUMO1 target SP100. These findings place sumoylation at the cytoplasmic filaments of the nuclear pore complex and suggest that, for some substrates, modification and nuclear import are linked events. This gene is partially duplicated in a gene cluster that lies in a hot spot for recombination on chromosome 2q. [provided by RefSeq, Jul 2008]
RANBP2 Gene-Disease associations (from GenCC):
- familial acute necrotizing encephalopathyInheritance: AD Classification: STRONG, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- Leigh syndromeInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.00480482).
BP6
Variant 2-108765299-G-T is Benign according to our data. Variant chr2-108765299-G-T is described in ClinVar as Benign. ClinVar VariationId is 469463.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 296 AD gene.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| RANBP2 | ENST00000283195.11 | c.4760G>T | p.Gly1587Val | missense_variant | Exon 20 of 29 | 1 | NM_006267.5 | ENSP00000283195.6 | ||
| RANBP2 | ENST00000697737.1 | c.2603-6402G>T | intron_variant | Intron 18 of 26 | ENSP00000513426.1 | |||||
| RANBP2 | ENST00000697740.1 | c.2525-6402G>T | intron_variant | Intron 18 of 26 | ENSP00000513427.1 |
Frequencies
GnomAD3 genomes AF: 0.00195 AC: 296AN: 152174Hom.: 1 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
296
AN:
152174
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00211 AC: 530AN: 251214 AF XY: 0.00211 show subpopulations
GnomAD2 exomes
AF:
AC:
530
AN:
251214
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00145 AC: 2119AN: 1461768Hom.: 6 Cov.: 36 AF XY: 0.00144 AC XY: 1049AN XY: 727190 show subpopulations
GnomAD4 exome
AF:
AC:
2119
AN:
1461768
Hom.:
Cov.:
36
AF XY:
AC XY:
1049
AN XY:
727190
show subpopulations
African (AFR)
AF:
AC:
4
AN:
33420
American (AMR)
AF:
AC:
59
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
AC:
8
AN:
26136
East Asian (EAS)
AF:
AC:
0
AN:
39698
South Asian (SAS)
AF:
AC:
1
AN:
86256
European-Finnish (FIN)
AF:
AC:
640
AN:
53414
Middle Eastern (MID)
AF:
AC:
3
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
1324
AN:
1111968
Other (OTH)
AF:
AC:
80
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
172
344
515
687
859
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00194 AC: 296AN: 152292Hom.: 1 Cov.: 31 AF XY: 0.00231 AC XY: 172AN XY: 74466 show subpopulations
GnomAD4 genome
AF:
AC:
296
AN:
152292
Hom.:
Cov.:
31
AF XY:
AC XY:
172
AN XY:
74466
show subpopulations
African (AFR)
AF:
AC:
4
AN:
41576
American (AMR)
AF:
AC:
26
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
2
AN:
5184
South Asian (SAS)
AF:
AC:
1
AN:
4822
European-Finnish (FIN)
AF:
AC:
137
AN:
10604
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
121
AN:
68038
Other (OTH)
AF:
AC:
5
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
13
25
38
50
63
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
10
ExAC
AF:
AC:
242
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Aug 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
RANBP2: BP4, BS1, BS2 -
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Familial acute necrotizing encephalopathy Benign:1
Dec 07, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
DANN
Uncertain
DEOGEN2
Uncertain
D
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M
PhyloP100
PrimateAI
Benign
T
PROVEAN
Uncertain
D
REVEL
Benign
Sift
Uncertain
D
Sift4G
Uncertain
D
Polyphen
P
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.